MRANK-108

N/A

Report date: 2023/11/24 13:26:00
First In Class

Base Information

Drug NameMRANK-108
Drug Alias NameMRANK-108
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsColorectal NeoplasmsTriple Negative Breast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesMindRank Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMindRank Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsColorectal NeoplasmsTriple Negative Breast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A